The global functional mushroom market was valued at over £8 billion in 2023 and is forecast to grow at a compound annual rate of more than 9% through the decade. For years, Asian producers — predominantly in China and Japan — have dominated both the supply chain and the cultural narrative around medicinal mushrooms. That is beginning to change, and the shift is being driven by something European brands do exceptionally well: trust.
The trust gap in the functional ingredient market
Consumers shopping for mushroom-based supplements — whether for ergothioneine, reishi triterpenes, lion’s mane, or beta-glucan complexes — are increasingly scrutinising origin, certification, and supply chain transparency. This scrutiny is not irrational. Multiple investigations over the past decade have found inconsistencies in ingredient concentrations and contamination concerns in imported mushroom extracts. The EU’s stricter import controls and organic certification frameworks have made European-grown alternatives significantly more attractive to both direct consumers and B2B buyers.
The shift is especially pronounced in the premium and clinical-grade segment, where health-conscious buyers are willing to pay a significant premium for verifiable quality. European certification — organic, non-GMO, locally traceable — is not just a marketing claim in this context; it is a meaningful differentiator.
Ergothioneine: The ingredient investors should know
At the science end of this market, ergothioneine is generating significant attention. A sulfur-containing amino acid found primarily in mushrooms, EGT has accumulated a compelling clinical evidence base over the past five years. A 21-year prospective study of over 3,200 participants found higher plasma ergothioneine levels independently associated with 21% lower cardiovascular mortality. A 2025 review in the Proceedings of the Nutrition Society synthesised growing evidence linking low EGT levels to cognitive decline, frailty, and mortality across multiple study designs.
The European Food Safety Authority approved ergothioneine as a novel food in 2017 — giving EU-based brands a regulatory head start that competitors in less-regulated markets cannot easily replicate. This creates a genuine first-mover advantage for UK and European companies willing to build around clinically substantiated, regulatory-compliant ergothioneine products.
The cosmeceuticals opportunity
Beyond the supplement aisle, the cosmeceuticals market represents an equally compelling channel. Ergothioneine has demonstrated the ability to protect skin cells against UV-induced DNA damage, reduce oxidative stress, and moderate melanin production. A 2023 clinical trial showed measurable improvements in pore size, wrinkles, UV spots, and skin tone following oral ergothioneine supplementation — positioning it squarely within the beauty-from-within trend that is currently one of the fastest-growing segments in personal care.
Reishi triterpenes offer a parallel opportunity in the anti-inflammatory and adaptogen space, with a narrative that combines millennia of traditional use with an increasingly robust modern evidence base. For brands targeting the premium wellness consumer — typically educated, female, 35–55, urban — reishi and ergothioneine together offer a powerful dual-ingredient story.
What does a winning European brand look like?
The most defensible position in this market combines four elements: certified organic European sourcing; transparent supply chain documentation; clinical substantiation at meaningful doses (10–25 mg EGT per serving); and clean-label formulation with no unnecessary additives. Brands that can tick all four boxes are competing in a different tier from the commoditised supplement market, and commanding margins to match.
Distribution channels worth prioritising include direct-to-consumer e-commerce (where longevity-focused consumer communities are highly engaged), premium independent health retailers, and B2B ingredient supply to the functional food and prestige skincare sectors. Nutraway Science a young growing start-up is filling in this gap with their market approach with existing and new potential partners.
The moment is now
The functional mushroom category is at an inflection point. Consumer awareness is rising, the science is maturing, and regulatory frameworks in Europe are more favourable than anywhere else in the world. The brands that establish credibility now — with rigorous sourcing, meaningful doses, and honest communication about what the evidence shows and what it doesn’t — will be well positioned when this market reaches its mainstream phase.
For London’s entrepreneurial community, this is a category worth watching closely. The competitive window is open, but it won’t stay that way for long.
Sources: Grand View Research Functional Mushroom Market Report (2023); Proceedings of the Nutrition Society (2025); Heart (2020); EFSA Novel Food Opinion (2017); Nutraceuticals (2025).
Leave a Comment